(Q40822804)

24 September 2017

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities (English)

1 reference

24 September 2017

16

1 reference

24 September 2017

Volker Hovestadt

7

0 references

Stefan M. Pfister

Stefan M Pfister

21

0 references

Michael Weller

23

Michael Weller

1 reference

24 September 2017

25

Wolfgang Wick

1 reference

PubMed ID

26087904

24 September 2017

Melanie Bewerunge-Hudler

8

Melanie Bewerunge-Hudler

1 reference

24 September 2017

3

Felix Sahm

1 reference

24 September 2017

27

Andreas von Deimling

1 reference

24 September 2017

18

Guido Reifenberger

1 reference

24 September 2017

4

David Capper

1 reference

PubMed ID

26087904

24 September 2017

Christel Herold-Mende

24

Christel Herold-Mende

1 reference

24 September 2017

10

Jens Schittenhelm

1 reference

24 September 2017

5

Daniel Schrimpf

1 reference

24 September 2017

11

Michel Mittelbronn

1 reference

24 September 2017

22

Andrey Korshunov

1 reference

24 September 2017

9

David T W Jones

1 reference

24 September 2017

1

David E Reuss

1 reference

24 September 2017

20

Kenneth Aldape

1 reference

24 September 2017

12

Elisabeth Rushing

1 reference

24 September 2017

2

Annekathrin Kratz

1 reference

24 September 2017

6

Christian Koelsche

1 reference

24 September 2017

13

Matthias Simon

1 reference

24 September 2017

14

Manfred Westphal

1 reference

24 September 2017

17

Werner Paulus

1 reference

24 September 2017

26

Sebastian Brandner

1 reference

24 September 2017

19

Joerg-Christian Tonn

1 reference

24 September 2017

Andreas Unterberg

15

1 reference

24 September 2017

19 June 2015

1 reference

24 September 2017

Acta Neuropathologica

1 reference

24 September 2017

130

1 reference

24 September 2017

407-417

1 reference

24 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s00401-015-1454-8

24 September 2017

0 references

cites work

Analysis of the IDH1 codon 132 mutation in brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

What do we know about IDH1/2 mutations so far, and how do we use it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Mutational landscape and clonal architecture in grade II and III gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-015-1454-8

10.1007/S00401-015-1454-8

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

26087904